(Q34570728)

3 August 2017

1 reference

title

DNA vaccines: future strategies and relevance to intracellular pathogens (English)

1 reference

3 August 2017

Sharma AK

1

1 reference

3 August 2017

Khuller GK

series ordinal

2

1 reference

3 August 2017

publication date

1 December 2001

1 reference

Immunology & Cell Biology

3 August 2017

published in

1 reference

3 August 2017

volume

79

1 reference

3 August 2017

issue

6

1 reference

3 August 2017

page(s)

537-546

1 reference

Generation of MHC class I-restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: antigen presentation by non-muscle cells

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01044.X

DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01044.X

First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01044.X

Immunostimulatory DNA sequences necessary for effective intradermal gene immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01044.X

Generating and regulating immune responses through cutaneous gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01044.X

Delivery of DNA vaccines by attenuated intracellular bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01044.X

DNA vaccines: a novel approach to immunization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01044.X

The immunobiology of muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01044.X

DNA immunization can stimulate florid local inflammation, and the antiviral immunity induced varies depending on injection site

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01044.X

Immune-mediated destruction of transfected muscle fibers after direct gene transfer with antigen-expressing plasmid DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01044.X

Involvement of an ATP-Dependent Peptide Chaperone in Cross-Presentation After DNA Immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01044.X

T cell expression cloning of a Mycobacterium tuberculosis gene encoding a protective antigen associated with the early control of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01044.X

Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01044.X

Safety, tolerability and humoral immune responses after intramuscular administration of a malaria DNA vaccine to healthy adult volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01044.X

Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01044.X

Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01044.X

Induction of CD8+ T cells using heterologous prime-boost immunisation strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01044.X

DNA vaccination against tuberculosis: expression of a ubiquitin-conjugated tuberculosis protein enhances antimycobacterial immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01044.X

Identification of potential CD8+ T-cell epitopes of the 19 kDa and AhpC proteins from Mycobacterium tuberculosis. No evidence for CD8+ T-cell priming against the identified peptides after DNA-vaccination of mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01044.X

Vaccination against tuberculosis by DNA injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01044.X

Protection against tuberculosis by a plasmid DNA vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01044.X

Therapy of tuberculosis in mice by DNA vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01044.X

Vaccinia expression of Mycobacterium tuberculosis-secreted proteins: tissue plasminogen activator signal sequence enhances expression and immunogenicity of M. tuberculosis Ag85.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01044.X

Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01044.X

Persistence of HIV-1 Transcription in Peripheral-Blood Mononuclear Cells in Patients Receiving Potent Antiretroviral Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01044.X

Residual HIV-1 disease in the era of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01044.X

Control of HIV despite the Discontinuation of Antiretroviral Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01044.X

A striking property of recombinant poxviruses: efficient inducers of in vivo expansion of primed CD8(+) T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01044.X

Mature dendritic cells infected with canarypox virus elicit strong anti-human immunodeficiency virus CD8+ and CD4+ T-cell responses from chronically infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01044.X

Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01044.X

Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01044.X

Gene inoculation generates immune responses against human immunodeficiency virus type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01044.X

Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01044.X

Safety and immunogenicity of HIV-1 DNA constructs in chimpanzees.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01044.X

Cationic liposomes are a strong adjuvant for a DNA vaccine of human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01044.X

Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01044.X

Heterologous protection against influenza by injection of DNA encoding a viral protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01044.X

21 January 2018

Immunization with DNA.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01044.X

Nucleic acid vaccine encoding gD2 protects mice from herpes simplex virus type 2 disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01044.X

DNA immunization against experimental genital herpes simplex virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01044.X

Protection against malaria by immunization with a Plasmodium yoelii circumsporozoite protein nucleic acid vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01044.X

Protection against mycoplasma infection using expression-library immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01044.X

Genes that induce immunity--DNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01044.X

Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01044.X

DNA immunization protects nonhuman primates against rabies virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01044.X

Potentiation of antigen-specific, Th1 immune responses by multiple DNA vaccination with an ovalbumin/interferon-gamma hybrid construct

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01044.X

Distribution of DNA vaccines determines their immunogenicity after intramuscular injection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01044.X

Immunogenicity and protective efficacy of a tuberculosis DNA vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01044.X

Three different putative phosphate transport receptors are encoded by the Mycobacterium tuberculosis genome and are present at the surface of Mycobacterium bovis BCG

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01044.X

Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01044.X

Enhanced responses to a DNA vaccine encoding a fusion antigen that is directed to sites of immune induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01044.X

10.1046/J.1440-1711.2001.01044.X

21 January 2018

Identifiers

DOI

1 reference

release_72pzo6nyrbczhji5lc7qjh446q

3 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/72pzo6nyrbczhji5lc7qjh446q

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference